Growth Metrics

Alnylam Pharmaceuticals (ALNY) EBT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13,122.00
Dec 31, 2025 15,680.00
Sep 30, 2025 22,306.00
Jun 30, 2025 16,655.00
Mar 31, 2025 17,471.00
Dec 31, 2024 35,315.00
Sep 30, 2024 27,652.00
Jun 30, 2024 48,702.00
Mar 31, 2024 53,144.00
Dec 31, 2023 97,225.00
Sep 30, 2023 1.19 Mn
Jun 30, 2023 46,061.00
Mar 31, 2023 59,114.00
Dec 31, 2022 31,324.00
Sep 30, 2022 56,551.00
Jun 30, 2022 62,111.00
Mar 31, 2022 45,364.00
Dec 31, 2021 54,807.00
Sep 30, 2021 65,646.00
Jun 30, 2021 94,950.00
Mar 31, 2021 128,973.00
Dec 31, 2020 105,251.00
Sep 30, 2020 101,370.00
Jun 30, 2020 65,043.00
Mar 31, 2020 9,364.00
Dec 31, 2019 -20,483.00
Sep 30, 2019 10,210.00
Jun 30, 2019 11,978.00
Mar 31, 2019 270,419.00
Dec 31, 2018 -73,311.00
Sep 30, 2018 -1.15 Mn
Jun 30, 2018 -30,428.00
Mar 31, 2018 -59,376.00
Dec 31, 2017 -88,875.00
Sep 30, 2017 -60,273.00
Jun 30, 2017 -68,125.00
Mar 31, 2017 -51,066.00
Dec 31, 2016 -85,984.00
Sep 30, 2016 -70,164.00
Jun 30, 2016 -96,783.00
Mar 31, 2016 -132,403.00
Dec 31, 2015 -117,076.00
Sep 30, 2015 -118,057.00
Jun 30, 2015 -76,572.00
Mar 31, 2015 -22,615.00
Dec 31, 2014 -15,011.00
Sep 30, 2014 -36,006.00
Jun 30, 2014 -51,990.00